@ARTICLE{
author={Rudin CM|,Dowlati A|,Chen Y|,Navarro Mendivil AF|,Yang JC-H|,Stojanovic Goran|,Rich P|,Andric Zoran G|0000-0002-1495-2729,Wu Y-L|,Chen H|,Zhang L|,Yeung S|,Benzaghou FM|,Paz-Ares L|,Bunn PA|},
year={2023},
title={RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC)},
journal={JOURNAL OF THORACIC ONCOLOGY},
volume={18},
number={4},
pages={S129-S130},
document_type={Meeting Abstract},
}